the brutal reality is rejection. No point sugar coating this. I...

the brutal reality is rejection. No point sugar coating this. I sold out with a 40 percent haircut. The reasons are 3:
- Time which means money
- impact on the ards trial
- delayed rollout
The approval of this would have ensured The covid 19 trial transitions smoothly.
the time is a 12 to 18 month issue.
However, there is hope - the reason for the type A appeal request is to obtain a conditional approval - this could then be linked into the Ard trial involving covid patients. We are looking at December at earliest for an outcome here. In general MSB will be a good buy at the right price. However much if the sp was factoring in success. In the short term the big holders will try to gradually prop the stock and exit. I expect this volatility to continue with an optimistic announcement in the next few days outlining pathway. However once the major players exit this has a danger of filling in the gaps created from the lows in March.
Be patient before buying now. I would almost guarantee these prices will eventually test 2 dollars.